Related Experiment Video

Updated: Oct 14, 2026

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
11:19

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

The antigenic sites of trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties

S Mulot1, K K Chung, X B Li

  • 1Department of Biochemistry, The Chinese University of Hong Kong, Shatin, NT.

Life Sciences
|January 1, 1997
PubMed

Insights

Researchers identified key fragments of Trichosanthin (TCS) using mutagenesis and chemical cleavage. The smallest antigenic fragment spans the first 20 amino acids, revealing crucial details about TCS immunoreactivity.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Trichosanthin (TCS) is a ribosome-inactivating protein with potential therapeutic applications.
  • Understanding the immunoreactive regions of TCS is crucial for developing targeted therapies and diagnostic tools.

Purpose of the Study:

  • To map the antigenic determinants of Trichosanthin (TCS).
  • To identify specific fragments of TCS that elicit an immunoreactive response.
  • To characterize the nature of epitopes within the TCS protein.

Main Methods:

  • Production of C-terminally truncated TCS variants via Tn1000 deletion mutagenesis.
  • Generation of TCS fragments using cyanogen bromide (CNBr) cleavage.
  • Immunoreactivity assessment through antibody incubation.
  • Identification of protein fragments using electrospray mass spectrometry and N-terminal sequencing.

Main Results:

  • The smallest antigenic fragment of TCS was mapped to the N-terminal 20 amino acids.
  • Three immunoreactive CNBr fragments were identified, corresponding to amino acids 1-72, 101-152, and 153-246.
  • Fragments aa 1-72 and 153-246 reacted with the same monoclonal antibody, indicating a discontinuous epitope.
  • The fragment containing amino acids 73-100 showed no immunoreactivity with the antibodies used.

Conclusions:

  • Specific N-terminal and internal fragments of TCS contain important antigenic sites.
  • A discontinuous epitope is formed by amino acids within the 1-72 and 153-246 regions.
  • The 73-100 amino acid region of TCS does not appear to contain major B-cell epitopes recognized by the tested antibodies.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...